Antios Therapeutics

Atea Pharmaceuticals

This biopharmaceutical company develops oral antiviral therapies to treat patients with serious viral infections, including hepatitis C and hepatitis E.

Atea

This biopharmaceutical company develops oral antiviral therapies for patients with serious viral infections, including hepatitis C and other ribonucleic acid virus diseases.

Bluejay Therapeutics

The company develops monoclonal antibody therapies and small molecule drugs to treat patients with chronic hepatitis B, hepatitis D and other liver diseases.

AusperBio

This biopharmaceutical company develops oligonucleotide therapies and targeted delivery platforms for patients with chronic hepatitis B and other genetic or viral diseases.

Altesa BioSciences

This company develops antiviral medicines for patients with chronic lung diseases such as COPD and asthma to prevent respiratory infections and illness flare-ups.

Agenovir

This company develops nuclease-based anti-viral therapeutics to eliminate pathogenic viral genomes for healthcare providers treating patients with persistent viral infections.

Silverback Therapeutics

This biopharmaceutical company develops immune-modulating therapeutics for patients with cancer and chronic viral infections.

Excision Biotherapeutics

This biotechnology company develops CRISPR-based gene editing therapies designed to cure chronic viral infectious diseases for patients.